In Brief This Week: Broad Institute, CMS, Twist Bioscience, and More

The Scan

To Get Back Going

The head of Operation Warp Speed tells Bloomberg he expects the paused AstraZeneca and Johnson & Johnson vaccine trials to resume soon.

UK COVID-19 Disparities Report

A new UK government says socioeconomic factors, not genetics, account for disparities in deaths due to COVID-19 between ethnic groups, the Financial Times reports.

Trials Figure Out Paths Forward Despite Pandemic

NPR reports on an Alzheimer's disease drug trial that is continuing despite the pandemic.

Nature Papers Present CRISPR-Cas3 System to Make Large Genomic Deletions, Molecular Mechanisms of Chemoresistance in ALL

In Nature this week: CRISPR-Cas3 system for making large deletions efficiently, more.

Menu

In Brief This Week: Broad Institute, CMS, Twist Bioscience, and More

To read the full story....

Breaking News

Single-Cell Analysis of Colorectal Cancer Microenvironment Uncovers Somatic Copy Number Alterations

Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences

Ideaya Biosciences, Broad Institute Partner on Synthetic Lethality-Based Cancer Drug Discovery

Genetron Health Licenses ImmuQuad Technology for Blood Cancer Testing

Eurofins Q3 Revenues Rise 17 Percent on COVID-19 Testing

BioMérieux Q3 Revenues Increase 21 Percent

The Scan

To Get Back Going

UK COVID-19 Disparities Report

Trials Figure Out Paths Forward Despite Pandemic

Nature Papers Present CRISPR-Cas3 System to Make Large Genomic Deletions, Molecular Mechanisms of Chemoresistance in ALL

Sponsorships